SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-23-000042
Filing Date
2023-12-12
Accepted
2023-12-12 09:36:49
Documents
13
Period of Report
2023-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20231207.htm   iXBRL 8-K 39308
2 EX-99.1 pressrelease12-12x2023.htm EX-99.1 8857
  Complete submission text file 0001510964-23-000042.txt   168969

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20231207.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20231207_lab.xml EX-101.LAB 21370
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20231207_pre.xml EX-101.PRE 10994
7 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20231207_htm.xml XML 2439
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 231480160
SIC: 2834 Pharmaceutical Preparations